Empirico
PrivateLast Round
Series B
Mar 20, 2023
Total Funding Raised
$74.72M
Company Overview
Empirico is a biotechnology company that discovers and develops siRNA medicines designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Empirico Comparables
Compare Empirico with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Deep Genomics | 86% | |
| Insitro | 82% | |
| ADARx Pharmaceuticals | 81% |
Empirico Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 20, 2023 | ||||
| Series A Extension | Jan 9, 2020 | ||||
| Series A | Nov 1, 2018 |
Empirico Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCVC Bio | Series A Extension, Series A |
| New Enterprise Associates (NEA) | Series A |
| ARCH Venture Partners | Series A |
| Foresite Capital | Series A |
| Neotribe Ventures | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2020
$17M round led by Ionis Pharmaceuticals
- Nov 1, 2018
$13M round led by ARCH Venture Partners, DCVC Bio, and Neotribe Ventures.
Empirico Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Empirico's valuation, stock price, and market status.
Is Empirico a public or private company?
Empirico is a private company.
What is the current stock price of Empirico?
Empirico is a private company with no public stock price. No recent secondary market data is available.
How much is Empirico worth (valuation)?
Valuation information for Empirico is not publicly available.
Can I buy Empirico stock?
Empirico shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Empirico's last funding round?
Empirico's most recent funding round was Series B on March 20, 2023.
Who are the main investors in Empirico?
Key investors in Empirico include DCVC Bio, ARCH Venture Partners, Neotribe Ventures.
Will Empirico IPO soon?
No public IPO plans have been announced for Empirico.
How can I track Empirico secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Empirico's secondary market activity and sign up for updates.